← Back to Treatments
🏅 FDA Orphan Designation

Panretin

Alitretinoin

Manufacturer: Advanz Pharma (US) Corp.

Indicated for:
OBSOLETE: HIV-related Kaposi sarcomaOrphan

FDA-Approved Indications (1)

Topical treatment of cutaneous lesions in patients with AIDS-related Kaposi's sarcoma.

Indications & Usage

1 INDICATIONS AND USAGE 1.1 Kaposi’s Sarcoma PANRETIN GEL is indicated for topical treatment of cutaneous lesions in adults with AIDS related Kaposi’s sarcoma (KS). Limitations of Use: PANRETIN GEL is not indicated when systemic anti-KS therapy is required (including more than 10 new KS lesions in the prior month, symptomatic lymphedema, symptomatic pulmonary KS, or symptomatic visceral involvement) [see Clinical Studies ( 14.1 )] . PANRETIN GEL is a retinoid indicated for the topical treatment of cutaneous lesions in adults with AIDS-related Kaposi’s sarcoma (KS). Limitations of Use : PANRETIN GEL is not indicated when systemic anti-Kaposi’s sarcoma therapy is required.

💙 Support Programs

View all →
Panretin
Advanz Pharma (US) Corp.

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.